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Effect of potassium chloride on plasma renin activity and plasma
aldosterone during sodium restriction in normal man. The present
study was designed to evaluate the spectrum of responses of
PRA and plasma aldosterone (PAId) to a range of oral potassium
intakes (0 to 300 mEq of potassium chloride per day) in 20 normal
human subjects receiving an electrolyte-free diet. Potassium ex-
hibited a dose-dependent natriuretic effect. The results of the
PRA studies indicate that normal dietary amounts (50 mEq/day)
of potassium chloride do not prevent the increase in PRA with
absolute sodium deprivation and that PRA is maximally stimulat-
ed on 150 mEq of potassium chloride per day. The rise in PRA is
directly correlated with serum potassium concentration. The re-
sults of the PAIdO studies indicate that potassium chloride depriva-
tion attenuates P1d. increases due to sodium deprivation and
that PAISO is maximally stimulated on ISO mEq of potassium chlo-
ride per day. The rise in PAIdO is directly correlated with serum
potassium concentration and with PRA. The administration of
300 mEq/day of potassium chloride caused significant hyperka-
lemia and blunted both PRA and PAId. increases. Our results sug-
gest that potassium chloride has an important role in the regula-
tion of PRA and PAIdO, and that only following potassium chloride
deprivation is the PRAIPAIdO response dissociated.
Effet du chlorure de potassium sur l'activité rénine et
l'aldostérone plasmatiques au cours de Ia restriction de sodium
chez l'homme normal. Ce travail a pour but dëvaluer l'étendue
des responses de l'activité rénine (PRA) et de l'aldostérone
(PAld) plasmatiques a un éventail d'apports de potassium (0 a
300 mEq de chlorurc de potassium par jour) chez 20 sujets nor-
maux qui reçoivent une alimentation dCpourvue d'électrolytes.
L'administration de potassium determine une natriurèse dose
dépendante. L'étude de PRA indique qu'un apport alimentaire
normal de chlorure de potassium (50 mEq/jour) n'empêche pas
l'augmentation de PRA au cours de Ia restriction totale de so-
dium et que PRA est stimulée au maximum par un apport de 150
mEq de potassium par jour. L'augmentation de PRA est direct-
ement corrélCc it Ia concentration plasmatique de potassium. Le
résultat de l'étude de PAIdO indique que Ia restriction d'apport de
chlorure de potassium atténue laugmentation de PAId,, liée a la
restriction de sodium et que PMth, est stimulCe de facon maximale
par 150 mEq de potassium quotidiens. L'augmentation de PMdO
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est directement corrélée avec Ia concentration plasmatique du
potassium et avec PRA. L'administration de 300 mEq/jour de
chlorure de potassium determine une hyperkaliemie significative
et attdnue les augmentations de PRA et de PAISO. Nos résultats
suggerent que Ic chlorure de potassium a un role important dans
Ia regulation de PRA et de PAIdO et que Ia dissociation des ré-
ponses PRA et PAIdO n'est obtenue qu'au cours de Ia restriction
en chlorure de potassium.
Previous studies have suggested an important
role for potassium in the regulation of the renin-al-
dosterone system. Oral potassium chloride adminis-
tration suppresses the renin response to sodium
deprivation in normal human subjects [1-5J. Con-
versely, potassium infusions or oral potassium
loads in man produce increases in aldosterone se-
cretion, and potassium depletion consistently de-
creases aldosterone secretion [6—191.
Potassium has a well-known natriuretic effect [4,
201. Although the short-term effect of potassium ad-
ministration may be to suppress PRA via enhanced
sodium delivery to the macula densa, the long-term
effect might be to stimulate PRA by sodium deple-
tion. Under the latter circumstances, one might ex-
pect similar directional changes in both PRA and
plasma aldosterone (PA1d).
The present study was designed to evaluate the
PRA and PMdO responses in normal human patients
maintained on an electrolyte-free diet, with the ad-
dition of 0, 50, 150, or 300 mEq of potassium chlo-
ride per day to the formula. Studies were also per-
formed to assess the natriuretic effect of potassium
chloride.
Methods
Patients. Twenty normal human volunteers, on
an ad lib diet, were admitted to the Clinical Re-
search Center, University of Missouri Medical Cen-
ter, for protocol evaluation. Informed consent was
obtained according to the principles of the Declara-
tion of Helsinki. All studies were approved by the
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University of Missouri Committee for Research In-
volving Human Subjects. Patients ranged in age
from 22 to 43 years; 6 were female, 14 were male.
All were in excellent health as defined by a normal
history and physical examination.
Protocol. On the day of admission (day 0), pa-
tients maintained their usual diet. Baseline studies
were obtained on the morning of day 1 (see "Chem-
ical analyses"). Subjects were then placed on a diet
consisting of 30 calories/kg, 30 ml of fluid per kg
(including food water), and 1 g of protein per kg of
body wt. The basic diet contained essentially no so-
dium, potassium, or chloride. This was accom-
plished by utilizing a low-electrolyte food powder
(7000 J), Mead-Johnson Laboratories [21]. The
negligible content of sodium, potassium, and chlo-
ride of this formula, as tested by Mead-Johnson,
was confirmed in our laboratories. The diet was ad-
ministered in six to seven equal portions between
8:00 A.M. and 12:00 P.M.
Each patient underwent a 4-day protocol with the
alternate addition of either 0, 50, 150, or 300 mEq of
potassium chloride per day to the formula diet. Of
the 20 subjects, 13 underwent two or more separate
4-day study periods. On these occasions, the study
periods were separated by an interval of at least 3
days to allow the patients to return to or near their
baseline status of body weight and electrolyte ex-
cretion.
Recumbent blood pressures were measured on
day I and day 5. No consistent change was noted
for any study period.
Chemical analyses. During each study period,
daily 24-hour urine specimens were collected for
determination of sodium, potassium, chloride, and
creatinine concentrations. Daily serum potassium
determinations were made on patients receiving 300
mEq/day of potassium chloride. On day 1 and day
5, venous blood samples for measurement of PRA
and PAIdO were collected in the morning following 2-
hour recumbency, or upright posture. Daily intake,
output, and body weight were monitored.
Urinary sodium and potassium were measured
with a flame photometer (Instrumentation Labora-
tory, Lexington, Massachusetts). Urinary chloride
concentrations were quantified with a chloride titra-
tor (American Instrument Company, Travenol Lab-
oratories, Inc., Silver Spring, Maryland). Serum so-
dium, potassium, and chloride concentrations were
measured by autoanalyzer techniques, with an
autonalayzer (Autoanalyzer II, Technicon In-
struments Corp., Tarrytown, New York). Serum
total carbon dioxide was determined by a pH blood-
gas analyzer and acid-base calculator (Instrument
Laboratories, model 513). True creatinine concen-
trations in the urine were measured by a previously
described method [22].
Plasma renin activity (PRA) assay. Venous
blood samples were collected in chilled EDTA-con-
taming test tubes, spun in a refrigerated centrifuge
to separate plasma, and assayed according to a pre-
viously described radioimmunoassay for generated
angiotensin I 11231.
Plasma aldosterone (Ajd) assay. Venous blood
samples were collected in chilled heparin-contain-
ing test tubes, spun in a refrigerated centrifuge to
separate plasma, and assayed according to a pre-
viously described and highly specific radioimmuno-
assay for PAIdO 1124]. With this method, the recovery
of 3H-aldosterone in our laboratory averaged 56.6
2.3% (SD). The intraassay coefficient of variation
was 1.8%; the interassay coefficient of variation
was 2.8%.
Calculations. Creatinine clearances (mI/mm)
were calculated as [(urine/plasma conc.) x (24-hr
urine volume (ml/day)] [(1440 (mm/day)]. Daily
sodium, potassium, and chloride excretion rates
were calculated as (urine conc. x 24-hr urine vol-
ume) and were expressed as milliequivalents per
day. The mean cumulative sodium, potassium, and
chloride urinary losses during the 4-day study peri-
ods, with and without potassium chloride, were cal-
culated. Without potassium chloride administra-
tion, daily excretions of potassium, chloride, and
sodium represent net urinary losses, since intakes
were near zero. With potassium chloride adminis-
tration, potassium and chloride net urinary losses
(mEq/day) were calculated as urine excretion minus
50, 150, or 300 for the respective dietary intakes.
Statistics. The Wilcoxon rank sum test was used
to make comparisons when the groups were inde-
pendent; the Wilcoxon signed rank test was used to
make comparisons when the groups were matched
[25]. A difference was considered statistically sig-
nificant when P < 0.05. Linear (least squares) re-
gressions were constructed and correlation coeffi-
cients were determined to relate day-5 PAldo to
serum potassium concentration and to PRA, with a
desktop computer (Hewlett Packard model 9810).
Results
Table 1 shows the mean values for sodium, potas-
sium, and chloride excretion on respective days,
with and without potassium chloride. Baseline (day
0) values for sodium, potassium, and chloride ex-
cretion were not significantly different, with or
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Table 1. Urinary electrolyte excretion (mEq/day) and net losses (mEq) from day Ito day 5
Day 0 Day 1 Day 2 Day 3 Day 4 Net loss
NoKCI(N= 13)
Sodium 161 20 79 10 35 5 14 2 8 —156 16
Potassium 62 7 32 2 23 2 17 I 17 I —87 5
Chloride 143 15 106 18 51 6 29 5 14 2 —213 21
50 mEq/day KCI (N = 8)
Sodium 150 IS 99 17 55 II 26 4 17 2 —174 23
Potassium 59 6 43 4 44 2 44 3 49 3 + II II
Chloride 142 16 127 20 104 16 70 3 55 3 —123 26
ISO mEq/day KCI (N = 8)
Sodium 185 44 162 19 77 II 29 4 14 2 —282 30
Potassium 62 14 99 II 135 II 146 7 147 6 +74 29
Chloride 145 30 259 22 232 13 182 8 160 6 —232 32
300 mEq/day KCI (N = 5)
Sodium 201 47 211 21 82 3 39 7 16 I —337 34
Potassium 65 6 218 18 273 19 326 II 301 28 +42 18
Chloride 180 30 397 16 359 28 358 15 293 33 —267 7
Values are means SEM.
without potassium chloride. From day 1, the means
of sodium, potassium, and chloride excretion were
always greater in patients receiving 50, 150, or 300
mEq of potassium chloride, with differences achiev-
ing statistical significance at the level of P < 0.01.
The net loss of sodium over 4 days was significantly
(P < 0.05) greater with 50, 150, and 300 mEq of po-
tassium chloride, compared with no potassium
chloride. Additionally, potassium chloride had a
dose-dependent effect on urinary sodium loss. As
expected, there was a modest but significant (P <
0.05) net gain for potassium over the 4 days in pa-
tients receiving potassium chloride. This could re-
flect actual increases in total body potassium, or
greater stool losses of potassium, or both. Chloride
losses tended to parallel sodium losses over the 4-
day period.
Figure 1 shows the mean recumbent (panel A)
and upright (panel B) control (day 1) values of PRA
(nglmllhr) prior to the initiation of the 7000-J diet,
on day 5 of the study, a time when daily urinary
potassium excretion was near the intake value.
There were no significant differences in day 1 (con-
trol) values of all study groups. The administration
of the 7000-i diet, with and without potassium
chloride, caused a significant (P < 0,01) increase in
PRA compared with control values. The addition of
50 mEq of potassium chloride, however, did not
change the PRA response to the electrolyte-free
diet. PRA increments due to sodium deprivation
were significantly (P < 0.01) elevated following the
administration of 150 mEq of potassium chloride
per day, compared with 0 or 50 mEq of potassium
chloride per day. Although the mean PRA was in-
creased following the administration of 300 mEq/
day of potassium chloride, the change was not sig-
nificant. Two of the five subjects demonstrated sup-
pression of PRA.
Figure 2 shows the mean recumbent control (day
1) values of PAI(]() (ng/dl) prior to initiation of the
7000-J diet, on day 5 of the study, at a time when
daily urinary potassium was near intake. There were
no significant differences in day 1 (control) values
of all study groups. The administration of the 7000-J
diet, with or without potassium chloride, caused a
significant (P < 0.05) increase in PAj{li, compared
with control value. Atd() increments due to sodium
deprivation were modestly but significantly (P < 0.05)
attenuated by potassium deprivation (0 potassium
chloride vs. 50 mEq potassium chloride). PAI(1(, in-
creases with sodium deprivation were maximal on
150 mEq of potassium chloride/day: mean A1(t,
values at this level of potassium chloride intake
were significantly above those obtained at 50 mEq
of potassium chloride (P < 0.001) and 300 mEq
of potassium chloride (P < 0.05).
Table 2 shows the mean serum electrolyte con-
centrations on respective days during the study pe-
riods. Baseline (day I) electrolytes did not differ sig-
nificantly, with or without potassium chloride. The
only significant (P < 0.05) changes during the study
period were a decrease in serum sodium concentra-
tion following the administration of 150 or 300 mEq/
day of potassium chloride, an increase in the serum
potassium concentration following the administra-
tion of 300 mEq/day of potassium chloride, and a
decrease in the serum chloride concentration fol-
lowing the administration of the 7000-J diet, with
or without potassium chloride.
There was a significant (P < 0.01) direct correla-
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Fig. 1. Comparative recumbent (A) and upright (B) responses of PRA (ng/mllhr) to variable doses of potassium chloride (KCl)
(mEq/dav). C, = respective control (day 1) period for each study. 0, 50, 150, 300 K = day 5 responses to 0, 50, 150, or 300
mEq KCI/day.
tion (r = 0.468) between day-5 recumbent PRA and
serum potassium concentration (Fig. 3). As antici-
pated, there was a significant (P < 0.01) direct cor-
relation (y = 3. 15x + 42.0; r = 0.493) between day-5
recumbent PRA and PAIdO for all patients. Finally,
there was a significant (P < 0.01) direct correlation
(r = 0.518) between day-S PAldo and serum potas-
sium for all patients. This correlation was further
increased (r = 0.678) when patients receiving 300
mEq/day of potassium chloride were excluded (Fig.
4).
As evidenced in Fig. 3, two patients (both receiv-
ing 300 mEq/day of potassium chloride) exhibited
hyperkalemia (serum potassium, > 5.4 mEq/Iiter).
Physical examination and electrocardiographic
monitoring of these patients indicated no apparent
abnormality except for peaked T waves. With dis-
continuation of the potassium chloride load, each
patient rapidly corrected to a normokalemic state.
No further studies were performed at this potas-
sium dose.
Table 2. Serum electrolyte concentrations (mEq/Iiter)
Day I Day 3 Day 5
NoKCI(N= 13)
Sodium 142 1.0 142 1.0 42 1.0
Potassium 4.4 0.1 4.2 0.1 4.0 0.1
Chloride 104 1.0 102 1.0 101 1.0
CO2 content 27 1.0 29 1.0 28 1.0
5OmEq/day KCI (N = 8)
Sodium 141 1.0 141 1.0 4I 1.0
Potassium 4.6 0.2 4.7 0.1 4.7 0.1
Chloride 104 1.0 100 1.0 102 1.0
CO1 content 27 1.0 28 1.0 28 1.0
ISO mEq/day KCI (N = 8)
Sodium 141 1.0 142 1.0 138 1.0
Potassium 4.5 0.2 4.9 0.2 4.8 0.2
Chloride 105 1.0 103 1.0 101 1.0
CO2 content 26 .0 25 1.0 25 1.0
300 mEq/day KCI (N = 5)
Sodium 43 1.0 141 1.0 139 1.0
Potassium 4.2 0.2 5.0 0.4 4.8 0.4
Chloride 106 1.0 102 2.0 102 1.0
CO1 content 29 1.0 28 1.0 27 2.0
Values are means SEM.
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5.0 to 69.5 4.9 kg with 300 mEq/day of potassium
chloride.50
Significant (P < 0.05) mean creatinine clearance
= 6.2x -20.6 decreases were seen in all studies, except following40 r=0.468
p < ow the administration of 300 mEq!day of potassium
chloride. The mean (±sEM) clearance fell from 12230 9 to 98 6 mI/mm over day 1 to day 5 without
cm: 201- — potassium chloride, from 118 8 to 104 7 mI/mm
with 50 mEq/day of potassium chloride, and from
10 119 12 to 103 11 mI/mm with 150 mEq!day of
potassium chloride. Following the administration of
300 mEq!day of potassium chloride, the mean clear-
4 5 6 7
ance did not change significantly (day 1, 98 8 ml!Serum potassium, mEq/fiter
All subjects mm; day 4, 96 9 ml!min).
Fig. 3. Dan 5 relationship between recionbent PRA (ng/ml/hr)
and serum potasiumn concentration (mEqiliter) for ciii suljects on D1SCUSS1Ofl
lou-electrolyte food powder (7000 J) (cIci3' 5) without or with o- Plasma renin activity (PRA). The current studytussiumn chloride (KC'l).
was designed to assess the inhibitory effect that po-
tassium chloride administration might have on
PRA. Since renin substrate is not affected by potas-
Significant (P < 0.01) mean weight decreases sium administration [261, and since plasma renin
were seen in all studies. The mean (±sEM) weight concentration changes parallel PRA changes fol-
fell from 70.7 3.6 to 68.7 3.5 kg over day ito lowing potassium loads [27], the level of PRA was
day 5 without potassium chloride, from 67.7 4.7 considered to be an index of renin secretion. The
to 65.8 4.4 kg with 50 mEq/day of potassium amounts of potassium administered (150 or 300
chloride, from 77.8 3.7 to 75.2 3.6 kg with 150 mEq/day) were considered to be the "critical
mEq/day of potassium chloride, and from 71.5 amount' necessary to consistently induce suppres-
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sion of PRA [4]. The administration of 300 mEq/day
of potassium chloride, however, was found to be
hazardous, and studies at this dose were curtailed.
Our results demonstrate that the administration
of 150 mEq/day of potassium chloride to the for-
mula causes a significant increase in PRA compared
with control, and greater stimulation of PRA com-
pared with the response following the 7000-i diet
alone or to the response following the 7000-J diet
plus 50 mEq of potassium chloride per day. The
PRA response following the administration of
300 mEq/day of potassium chloride to the formula
was variable. Two patients demonstrated similar
levels of PRA stimulation following the administra-
tion of 300 mEq/day of potassium chloride, com-
pared with the PRA response in patients receiving
150 mEq/day of potassium chloride, and two sub-
jects demonstrated suppression of PRA. The latter
two subjects had the lowest mean cumulative so-
dium excretion (234 and 287 mEq), considerably
lower than the mean cumulative sodium excretion
for the group (337 mEq).
An evaluation of the urinary electrolyte excretion
data reveals that potassium chloride exhibited a
dose-dependent natriuretic effect. We previously
have reported a 25% increase from control in the
mean cumulative sodium excretion following the
administration of 50 mEq/day of potassium chloride
[231. In the current study, there was a 156% in-
crease from control in the mean cumulative sodium
excretion following the administration of 150 mEqI
day of potassium chloride and a 178% increase fol-
lowing the administration of 300 mEq/day of potas-
sium chloride.
A reduction in weight and glomerular filtration,
following a significant natriuresis, would be ex-
pected to stimulate PRA. The majority of our pa-
tients, unlike those of others [I—5j, demonstrated
stimulation of PRA following the administration of
the potent natriuretic agent (potassium chloride). In
the two patients receiving 300 mEq/day of potas-
sium chloride and demonstrating suppression of
PRA, the observed response may be due to their
relatively modest natriuretic effect when compared
with their peers.
In our studies, no significant increase in mean
morning-fasting serum potassium occurred follow-
ing the administration of 50 or 150 mEq/day of po-
tassium chloride to the formula, and mean GFR was
decreased. Therefore, increased mean intratubular
potassium concentration should have occurred only
distal to the sodium potassium exchange site, and
not in the proximal tubule. This may account for
lack of inhibition of renin secretion following the
administration of 50 or 150 mEq/day of potassium
chloride to the formula.
Significant increases in mean morning-fasting
serum potassium occurred following the administra-
tion of 300 mEq/day of potassium chloride to the
formula. The mean GFR on day 4 was not signifi-
cantly altered from that on day 0. It is therefore rea-
sonable to suggest that increased mean intratubular
potassium concentration could have occurred in the
proximal tubule or loop of Henle under these condi-
tions. According to the hypothesis of Vander [281,
this would allow for increased sodium delivery to
the macula densa and inhibition of renin release.
This effect of 300 mEq could account for the sup-
pression of PRA found in two patients in this group.
A significant direct relationship between PRA
and serum potassium concentration has not been re-
ported previously. These findings are in contrast to
previous related studies [1—51. Unlike other studies,
however, all of our patients were absolutely sodium
deprived through dietary means, and all of our pa-
tients underwent a significant natriuresis, associat-
ed with a significant weight loss. Only one previous
study has reported a natriuretic effect of potassium
chloride, and in that study the amounts of sodium
lost were not substantially different whether or not
PRA was suppressed [4].
Our results, and those of others, suggest that po-
tassium chloride has a dual effect on PRA: to stimu-
late PRA via its potent natriuretic properties, and to
suppress PRA by enhanced sodium delivery to the
macula densa. The former effect is dependent upon
net urinary losses of sodium with subsequent vol-
ume depletion; the latter is dependent on increases
in plasma potassium concentrations and large fil-
tered loads of potassium. Even under the latter cir-
cumstance, however, initial suppression of PRA
may be followed by "escape" [27, 29]. The effect of
potassium chloride on PRA in normal man will un-
doubtedly be the net response to the above oppos-
ing effects, and may explain the inconsistent PRA
responses to potassium chloride reported by others
[16, 20, 301.
Potassium concentration was initially determined
at 8:00 A.M. because plasma potassium peaks in the
early morning, whereas urinary potassium excre-
tion is at its minimum [31J. Under the circum-
stances of this protocol, however, potassium
peaked following the oral administration of potas-
sium chloride, a finding to be emphasized in terms
of its potential harm to experimental subjects. Upon
recognition of the latter, we discontinued further
studies utilizing 300 mEq!day of potassium chlo-
ride. This complication has not been reported pre-
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viously by investigators performing similar studies
in man using potassium chloride loads of 200 to 220
mEqlday.
Plasma aldosterone Increases in serum
potassium of 0.1(0 1.5 mEq/liter above control lev-
els have been reported in man to be associated with
significant increments in PAIdO, with the most sensi-
tive area of the dose-response curve being between
0.1 and 0.5 mEq/Iiter [14, 19]. Furthermore, these
increments in plasma potassium produced by potas-
sium chloride infusion had no significant effect on
PRA. In anephric man, a positive correlation has
been reported between PAIOOand potassium concen-
tration [32, 331.
Our study is the first to report the response of
PAId0 to a range of oral potassium chloride loads in
man. Our results indicate that increases in AIdo af-
ter sodium deprivation are attenuated by potassium
deprivation (0 mEq/day vs. 50 mEq/day of potas-
sium chloride), and that this is accompanied by a
mean decrease in serum potassium concentration.
Increases in PAIdOafter sodium deprivation are max-
imal following 150 mEq/day of potassium chloride
and are accompanied by a mean increase in plasma
potassium concentration. Furthermore, PAldo in-
creases are correlated directly with serum potas-
sium concentrations, particularly when serum po-
tassium concentration is within a normal physiolog-
ical range (3.5 to 5.4 mEq/liter).
Mean PAIdO increases with sodium deprivation are
modestly blunted with 300 mEq/day potassium
chloride loads compared with the response follow-
ing 150 mEq/day of potassium chloride. Two of the
five patients demonstrated hyperkalemia, and their
PAId( responses (6.9 to 111 and 7.0 to 61.7 ng!dI)
were lower than would have been anticipated com-
pared with the response in patients receiving 150
mEq/day of potassium chloride. These two patients
exhibited stimulation of PRA (1.0 to 7.3 and 1.0 to
19.9 ng/ml/hr) similar to that of the patients receiv-
ing 150 mEq/day of potassium chloride.
Alterations of in vitro potassium concentration
have been reported to change the steroid output of
isolated rat zona glomerular cells, both unstimu-
lated and maximally stimulated with angiotensin
[34, 35J. Aldosterone output increases as a function
of potassium concentration (from 2 to 8.4 mM). Al-
dosterone release is inhibited, however, when the
potassium concentration of the incubation media
exceeds 8.5 ms'i. It is possible that conditions pro-
ducing hyperkalemia in man may result likewise in
inhibition of aldosterone release.
Although the renin-angiotensin system has been
considered the dominant regulator of aldosterone
secretion, with potassium and adrenocorticotropin
hormone playing minor roles, recent studies have
presented evidence of an increasingly important
role for the potassium ion in the regulation of al-
dosterone secretion [14, 18, 191. Our results support
these findings and, furthermore, suggest that only
following potassium chloride deprivation is the
PRA-PAIdO response dissociated.
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